Dr. Troy Grennan (he/him) is the Physician Lead of the HIV/STI Program at the BC Centre for Disease Control, and a Clinical Associate Professor in the Department of Medicine at the University of British Columbia. He is an infectious diseases physician and researcher, where both his clinical and research work focus on sexually transmitted infection (STI) treatment and prevention, HIV, HPV and anal cancer screening, and 2S/LGBTQI+ health. Dr. Grennan holds a Health Professional-Investigator Award from Michael Smith Health Research BC, is Vice-Chair of the Public Health Agency of Canada’s National Advisory Committee on Sexually Transmitted and Bloodborne Infections, Regional Co-Lead of the CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research, and incoming President of the International Anal Neoplasia Society (IANS). He currently is Co-Principal Investigator on two large Canadian studies: the PEACH study, an anal cancer screening study examining novel biomarkers in persons living with HIV, and the DISCO study, a randomized controlled trial of doxycycline pre- and post-exposure prophylaxis for STI prevention.